Aperio to Present at 30th Annual J.P. Morgan Healthcare Conference

VISTA, Calif.--(BUSINESS WIRE)-- Aperio, the global leader in digital pathology solutions that improve patient care, today announced that David Schlotterbeck, chief executive officer, will present an overview of the company’s business at the 30th Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2012, at the Westin St. Francis Hotel in San Francisco. The Aperio presentation is scheduled to begin at 10:00 a.m. (PST).

During his formal presentation, Mr. Schlotterbeck will discuss the multi-billion dollar digital pathology market and highlight Aperio’s new direction in digital pathology solutions for both healthcare and life sciences. These solutions will accelerate adoption and allow pathologists to be more effective.

About Aperio

Aperio is the leading provider of digital pathology solutions in hospitals, reference labs, and pharmaceutical and research institutions across the world. Today, our affordable and complete product portfolio improves patient care by enhancing quality assurance, delivering more efficient workflows, facilitating access to new and more targeted therapies, and improving pathologists’ skills via lifelong education. Our comprehensive product line features our ScanScope® scanners, Spectrum™ image management (PACS) software, SecondSlide® slide sharing service for pathology, and image analysis tools and services. Aperio’s products are FDA cleared for specific clinical applications, and are intended for research and education use for other applications. For clearance updates and more information please visit www.aperio.com.


Carol Thornton
Manager, Public Relations
[email protected]

KEYWORDS:   United States  North America  California

INDUSTRY KEYWORDS:   Technology  Data Management  Software  Practice Management  Health  Hospitals



Suggested Articles

Health insurance startup Bind scored a $105 million series B funding round backed by Ascension Ventures and UnitedHealth.

The Food and Drug Administration has granted breakthrough designation to AppliedVR's platform that treats chronic lower back pain.

Here's how the COVID-19 pandemic changed healthcare executives' focus on technology and what to expect in 2021.